|
|
News Breaks | | | | September 10, 2012 | | 08:34 EDT |  | SNT | Senesco Technologies announces results of combination of bortezomib and SNS01-T
Senesco Technologies announced that the combination of bortezomib (the active component of VELCADE marketed by Millennium, The Takeda Oncology Company) and SNS01-T, the subject of Senesco’s on-going multiple myeloma clinical study, performs significantly better than either treatment alone in mouse xenograft models. | |
|
News For SNT From The Last 14 Days Check below for free stories on SNT the last two weeks. |
|
|
| There are no results for SNT |
|
|
|
|
|
|
